“Glenmark Pharmaceuticals is primed for a breakout, currently consolidating after a good recovery and sitting at the edge of breaking out of its range with a constructive broader chart pattern. He recommends buying at Rs 2,205, targeting Rs 2,310, with a stop loss at Rs 2,150.”

Nagaraj Shetti’s track record: 6 graded calls · 95% CI 19–81%